Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-FR Version v2-FR
Language French French
Date Updated 2018-02-26 2017-12-12
Drug Identification Number 02258218 02258218
Brand name IRINOTECAN HYDROCHLORIDE INJECTION IRINOTECAN HYDROCHLORIDE INJECTION
Common or Proper name IRINOTECAN IRINOTECAN
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients IRINOTECAN HYDROCHLORIDE IRINOTECAN HYDROCHLORIDE
Strength(s) 20MG 20MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 1 x 2mL 1 x 2mL
ATC code L01XX L01XX
ATC description OTHER ANTINEOPLASTIC AGENTS OTHER ANTINEOPLASTIC AGENTS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2018-04-09 2018-01-11
Actual start date
Estimated end date 2018-02-26
Actual end date 2018-02-26
Shortage status Avoided shortage Anticipated shortage
Company comments
Health Canada comments